Tradestie Institutional Equity Comparison Engine

VVOS vs ABNG โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABNG Overall Edge

ABNG Captures Institutional Edge (2โ€“1 Pillars ยท 3โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ABNG (ABNG) driven by superior Momentum & Technical, Options & Structure while VVOS counters with relative strength in Growth & Margin. Fundamentally, VVOS trades at N/M Forward P/E with -107.9% operating margin (+34.9% YoY revenue) versus ABNG at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, VVOS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against ABNG sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
VVOS N/M vs ABNG N/M Fwd P/E
Growth & Margin Winner VVOS
Op Margin -107.9% vs N/A ยท YoY +34.9% vs N/A
Momentum & Technical Winner ABNG
1Y -97.7% vs +45.3% ยท 52W Pos 0% vs 100%
Options & Structure Winner ABNG
BREAKDOWN (N/A IV) vs UNCLASSIFIED (N/A IV)
VVOS NASDAQ
Vivos Therapeutics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.05
-5.1% 1D
Market Cap $1.9M
1M Return -59.25%
1Y Return -97.71%
Forward P/E N/M
Unified AI Score
36.4 / 100 SELL
Tech 25.0 Fund 35.0 Flow 50.0 Mom 30.0
ABNG US Equity
ABNG
Institutional Equity
$20.21
+8.39% 1D
Market Cap N/A
1M Return +8.73%
1Y Return +45.31%
Forward P/E N/M
Unified AI Score
53.0 / 100 HOLD
Tech 55.0 Fund 56.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VVOS -97.71% ABNG +45.31% Spread: +135.45 pp (ABNG Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
VVOS TTM Op. Margin: -107.9% ABNG TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VVOS vs ABNG. Trailing 12-month operating profitability (VVOS -107.9% vs ABNG N/A) and valuation multiples (VVOS N/M vs ABNG N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VVOS (5) vs ABNG (3)
Institutional Metric VVOS ABNG Criterion Row Winner
Market Capitalization Scale $1.9M N/A Larger Scale VVOS
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +34.9% N/A Higher Growth VVOS
Operating Margin (TTM) Profitability -107.9% N/A Higher Margin VVOS
Net Profit Margin Profitability -121.8% N/A Higher Margin VVOS
Return on Equity (ROE) Capital Efficiency -8585.3% N/A Higher ROE VVOS
52-Week Range Position Momentum 0% ($0โ€“$3) 100% ($13โ€“$20) Stronger Trend ABNG
Beta / 30D Volatility Risk Regime 1.70ฮฒ ยท 111% Vol 2.34ฮฒ ยท 71% Vol Lower Realized Risk ABNG
Unified Institutional Score Composite Signal 36.4 / 100 (SELL) 53.0 / 100 (HOLD) Higher Composite ABNG

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VVOS vs ABNG Buy Guide
VVOS BREAKDOWN
113d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live VVOS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ABNG UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ABNG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VVOS nor ABNG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.